StockData
CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc. (CASIF) stock

CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on May 15, 2026Score 1/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

CASI Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

CASI Pharmaceuticals's enterprise value was $15.62M on Oct 19, 2026, against $27.23M a year earlier. Over the last 5 years it ranged from -$23.55M to $99.41M, with a median of $20.72M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$15.62M-13.7%
2025Dec 31, 2025$18.09M-34.6%
2024Dec 31, 2024$27.66M-42.1%
2023Dec 29, 2023$47.78M–
2022Dec 30, 2022-$23.55M-126.7%
2021Dec 31, 2021$88.36M–

More CASI Pharmaceuticals figures

See a number that looks wrong?